Angela Hückelhoven‐Krauss

Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients

Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert et al. · International Journal of Cancer · 2019 · 78 citations · Full text

Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients

Fuli Fan, Sophia Stock, Lei Wang et al. · International Journal of Cancer · 2020 · 68 citations · Full text

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock et al. · Cancer Immunology Immunotherapy · 2019 · 50 citations · Full text

Inflammation, Autoimmune Disease, T-regulatory Cell +10

Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients

Alexander Kunz, Ulrike Gern, Anita Schmitt et al. · Molecular Therapy — Methods & Clinical Development · 2020 · 50 citations · Full text

Third-Generation CAR T Cells Targeting CD19 Are Associated with an Excellent Safety Profile and Might Improve Persistence of CAR T Cells in Treated Patients

Maria‐Luisa Schubert, Anita Schmitt, Brigitte Neuber et al. · Blood · 2019 · 46 citations